Literature DB >> 2822255

Transcription factor AP-2 mediates induction by two different signal-transduction pathways: protein kinase C and cAMP.

M Imagawa1, R Chiu, M Karin.   

Abstract

We have purified and characterized the 50 kd activator protein 2 (AP-2), another enhancer-binding protein interacting with the human metallothionein IIA (hMT-IIA) gene control region. Purified AP-2 activates transcription in vitro from a hybrid promoter containing hMT-IIA upstream sequences. AP-2 also recognizes control elements of the human growth hormone, c-myc, and H-2Kb genes, and the SV40 and bovine papilloma virus enhancers. Multiple synthetic copies of the hMT-IIA high-affinity AP-2 binding site can act as efficient, cell-type-specific enhancer elements; their activity increases after treatment of cells with phorbol ester or cAMP-elevating agents. In contrast, a synthetic enhancer recognized by factor AP-1 is activated only by phorbol ester. AP-2 appears to mediate transcriptional activation in response to two different signal-transduction pathways, one involving the phorbol-ester- and diacylglycerol-activated protein kinase C, the other involving cAMP-dependent protein kinase A.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2822255     DOI: 10.1016/0092-8674(87)90152-8

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  311 in total

1.  Expression, DNA-binding specificity and transcriptional regulation of nuclear factor 1 family proteins from rat.

Authors:  S Osada; T Matsubara; S Daimon; Y Terazu; M Xu; T Nishihara; M Imagawa
Journal:  Biochem J       Date:  1999-08-15       Impact factor: 3.857

2.  Transcriptional regulation of the Kaposi's sarcoma-associated herpesvirus viral interferon regulatory factor gene.

Authors:  J Chen; K Ueda; S Sakakibara; T Okuno; K Yamanishi
Journal:  J Virol       Date:  2000-09       Impact factor: 5.103

3.  Transcription factor AP-2alpha is preferentially cleaved by caspase 6 and degraded by proteasome during tumor necrosis factor alpha-induced apoptosis in breast cancer cells.

Authors:  O Nyormoi; Z Wang; D Doan; M Ruiz; D McConkey; M Bar-Eli
Journal:  Mol Cell Biol       Date:  2001-08       Impact factor: 4.272

4.  Characterization of a new tissue-specific transcription factor binding to the simian virus 40 enhancer TC-II (NF-kappa B) element.

Authors:  A L Lattion; E Espel; P Reichenbach; C Fromental; P Bucher; A Israël; P Baeuerle; N R Rice; M Nabholz
Journal:  Mol Cell Biol       Date:  1992-11       Impact factor: 4.272

5.  Multiple sequence elements of a single functional class are required for cyclic AMP responsiveness of the mouse c-fos promoter.

Authors:  L A Berkowitz; K T Riabowol; M Z Gilman
Journal:  Mol Cell Biol       Date:  1989-10       Impact factor: 4.272

6.  Inositol trisphosphate and diacylglycerol can differentially modulate gene expression in Dictyostelium.

Authors:  G Ginsburg; A R Kimmel
Journal:  Proc Natl Acad Sci U S A       Date:  1989-12       Impact factor: 11.205

7.  Interleukin 1 suppresses expression of cartilage-specific types II and IX collagens and increases types I and III collagens in human chondrocytes.

Authors:  M B Goldring; J Birkhead; L J Sandell; T Kimura; S M Krane
Journal:  J Clin Invest       Date:  1988-12       Impact factor: 14.808

8.  Distinguishable promoter elements are involved in transcriptional activation by E1a and cyclic AMP.

Authors:  K A Lee; J S Fink; R H Goodman; M R Green
Journal:  Mol Cell Biol       Date:  1989-10       Impact factor: 4.272

9.  Mechanism of cAMP regulation of renin gene transcription by proximal promoter.

Authors:  K Tamura; S Umemura; S Yamaguchi; T Iwamoto; S Kobayashi; A Fukamizu; K Murakami; M Ishii
Journal:  J Clin Invest       Date:  1994-11       Impact factor: 14.808

10.  A multiple cytokine- and second messenger-responsive element in the enhancer of the human interleukin-6 gene: similarities with c-fos gene regulation.

Authors:  A Ray; P Sassone-Corsi; P B Sehgal
Journal:  Mol Cell Biol       Date:  1989-12       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.